IPSC

Century Therapeutics (IPSC)

About Century Therapeutics (IPSC)

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Details

Daily high

$1.55

Daily low

$1.46

Price at open

$1.47

52 Week High

$5.51

52 Week Low

$1.28

Market cap

125.4M

Dividend yield

0.00%

Volume

180,358

Avg. volume

374,952

P/E ratio

-.73

Century Therapeutics News